About UroMems
UroMems is a company based in Grenoble (France) founded in 2011.. UroMems has raised $85.73 million across 6 funding rounds from investors including BNP Paribas, Crédit Agricole and Banque Populaire. UroMems offers products and services including UroActive. UroMems operates in a competitive market with competitors including Axonics, Amber Therapeutics, NeuSpera Medical, MyoPowers Medical Technologies and Levee Medical, among others.
- Headquarter Grenoble, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$85.73 M (USD)
in 6 rounds
-
Latest Funding Round
$47 M (USD), Series C
Jun 26, 2024
-
Investors
BNP Paribas
& 14 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of UroMems
UroMems offers a comprehensive portfolio of products and services, including UroActive. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Smart implant for treating severe stress urinary incontinence.
Unlock access to complete
Unlock access to complete
Funding Insights of UroMems
UroMems has successfully raised a total of $85.73M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $47 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $47.0M
-
First Round
First Round
(15 Nov 2016)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Series C - UroMems | Valuation | Crédit Mutuel Innovation | |
| Apr, 2021 | Amount | Series B - UroMems | Valuation | Financiere Arbevel , Supernova Invest | |
| May, 2020 | Amount | Debt – Conventional - UroMems | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in UroMems
UroMems has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include BNP Paribas, Crédit Agricole and Banque Populaire. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Long-term investments in startups are facilitated by this company.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is provided to innovative startups by b2venture.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by UroMems
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - UroMems
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Uromems Comparisons
Competitors of UroMems
UroMems operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Amber Therapeutics, NeuSpera Medical, MyoPowers Medical Technologies and Levee Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| domain | founded_year | HQ Location |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| domain | founded_year | HQ Location |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| domain | founded_year | HQ Location |
An implantable device for the treatment of urinary incontinence stress
|
|
| domain | founded_year | HQ Location |
Urological devices for post-prostatectomy incontinence are developed by Levee Medical.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Uromems
Frequently Asked Questions about UroMems
When was UroMems founded?
UroMems was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is UroMems located?
UroMems is headquartered in Grenoble, France. It is registered at Grenoble, Auvergne-rhone-alpes, France.
Is UroMems a funded company?
UroMems is a funded company, having raised a total of $85.73M across 6 funding rounds to date.
What does UroMems do?
Developer of active implantable devices for urological incontinence. The device MyoElectroMechanical System is based on a technology where a patients activity is measured in real-time through micro-sensors inside the implant into which algorithms are embedded; the system interprets data coming from the micro-sensors and computes the urethral pressure to apply.
Who are the top competitors of UroMems?
UroMems's top competitors include Axonics, NeuSpera Medical and Amber Therapeutics.
What products or services does UroMems offer?
UroMems offers UroActive.
Who are UroMems's investors?
UroMems has 15 investors. Key investors include BNP Paribas, Crédit Agricole, Banque Populaire, Caisse D Epargne, and European Commission.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.